Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Picking Apart the Cell’s Most Complex Structure

Published: Tuesday, May 22, 2012
Last Updated: Tuesday, May 22, 2012
Bookmark and Share
One of the most important structures in a cell is the nuclear pore complex — a tiny yet complicated channel through which information flows in and out of the cell’s nucleus, directing all other cell activity.

Little is known about this vital cell structure, but MIT biologist Thomas Schwartz is trying to change that. Using X-ray crystallography, he is steadily assembling a thorough portrait of the 500 proteins that make up nuclear pores, and how they come together to perform their crucial role.

“Nuclear transport is fundamental to life,” Schwartz says. “If you want to understand how a cell works, you need to understand how transport works.”

A cell’s nucleus is where all of its genetic material is stored in the form of DNA. Those genetic instructions are copied into messenger RNA, strands of which have to exit the nucleus so they can direct the cell’s protein synthesis. Proteins and other signaling molecules also pass through the nuclear pores. However, many questions remain unanswered about how the pores are assembled, and how they control so much activity.

“We don’t know how proteins that reside in the nuclear membrane actually get there. We don’t understand how viruses interact with the pore and how they go through. And we don’t understand how such an enormous spectrum of substrates can go through the same pore,” Schwartz says.

A complex task

Painstakingly piecing together the intricate interactions of the 500 proteins in the nuclear pore complex is a task well suited to the analytical Schwartz. Born in Stuttgart, Germany, Schwartz grew up surrounded by “people who think analytically,” he recalls. Stuttgart is home to many of Germany’s automobile manufacturers, and Schwartz’s father was an automotive engineer at Bosch, a company that makes fuel injection pumps. His mother also worked at Bosch; his brother grew up to become a software engineer.

“I was the odd one because I went into biology and chemistry. I was not really that much into physics. I liked chemical explosions when I was a kid,” says Schwartz, who earned tenure at MIT last June.

He studied biochemistry at Berlin’s Freie University, arriving on the day of German reunification in October 1990. After earning his bachelor’s degree, he continued at Freie for his PhD but spent three years as a visiting student at MIT, in the lab of legendary structural biologist Alexander Rich.

Working with Rich, who is best known for discovering the structures of left-handed DNA and transfer RNA, was “inspirational,” Schwartz says. “Freie University was a big university with lots of students and there wasn’t this personal touch that is so normal at MIT. Here, somebody will really care about what you are doing.”

In Rich’s lab, Schwartz used X-ray crystallography to figure out the structure of a protein that binds to left-handed DNA. X-ray crystallography — a way to image molecules by bombarding them with X-rays — appealed to him more than other scientific techniques, because “it’s a direct visual readout of a molecule’s function,” he says. That makes it easier to get a clear answer, instead of relying on data open to multiple interpretations.

After earning his PhD, Schwartz went back to Berlin for a year as a postdoc. However, he found that he missed the atmosphere at MIT. “People here essentially live science, so if that’s attractive to you, it’s hard to go anywhere else,” he says.

A fascinating structure

Schwartz decided to leave Berlin and did four years of postdoctoral work at Rockefeller University, where he continued his research in X-ray crystallography. Working with Günter Blobel, he became interested in the nuclear pore complex.

Around this time, protein purification techniques and computational tools greatly improved, making X-ray crystallography more accessible to more biology labs. Blobel’s lab at Rockefeller, which focused on cell biology, had recently started using X-ray crystallography to study how proteins are transported across membranes. Schwartz focused specifically on transport through the nuclear pore complex.

There are 30 different types of proteins found in each pore; each pore contains a total of about 500 protein molecules. “When you look at it from a structural perspective, it’s one of the most fascinating and largest assemblies that we know of in the cell,” Schwartz says.

At MIT, Schwartz and members of his lab are piecing together the structure of the pore by crystallizing a few of the proteins at a time, then combining the structures of overlapping sections.

Learning more about how nuclear pores work could help researchers come up with new ways to block retroviruses, such as HIV, that enter the cell’s nucleus and take over its genetic machinery.

“Any retrovirus needs to go through the pore,” Schwartz says. “If you really understood all the molecular interactions that happen there, you would have a totally new avenue for generating drugs. There’s not a single drug at this point that targets this process.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Kind of Microscope uses Neutrons
Device could open up new areas of research on materials and biological samples at tiny scales.
Friday, October 04, 2013
Precisely Engineering 3-D Brain Tissues
New design technique could enable personalized medicine, studies of brain wiring.
Thursday, November 29, 2012
Tracking Stem Cell Reprogramming
Biologists reveal genes key to development of pluripotency, in single cells.
Friday, September 14, 2012
Scientific News
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
Yeast Cells Use Signaling Pathway to Modify Their Genomes
Researchers at the Babraham Institute and Cambridge Systems Biology Centre, University of Cambridge have shown that yeast can modify their genomes to take advantage of an excess of calories in the environment and attain optimal growth.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
New Measurements Reveal Differences Between Stem Cells for Treating Retinal Degeneration
By growing two types of stem cells in a “3-D culture” and measuring their ability to produce retinal cells, a team lead by St. Jude Children’s Research Hospital researchers has found one cell type to be better at producing retinal cells.
Researchers Identify Critical Genes Responsible for Brain Tumor Growth
After generating new brain tumor models scientists have identified the role of a family of genes underlying tumor growth in a wide spectrum of high grade brain tumors.
Growing Spinal Disc Tissue
Scientists develop new method for growing spinal disc tissue in the lab for combating chronic back pain.
A New Path Towards a Universal Flu Vaccine
New research suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective and efficient vaccines against this ever-mutating virus.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Human Trials of Manufactured Blood Within Two Years
The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!